GMAB•benzinga•November 6, 2024 at 04:06 PM

Genmab Reports 29% Revenue Growth For First Nine Months Of 2024 To DKK 15.1B, Updates Full-Year Financial Guidance With Expected Revenue Of DKK 21.1B To DKK 21.7B And Gross Profit Of DKK 20.2B To DKK 20.8B

No summary available.

Read the full article from the original source for complete details and context.

Article published on November 6, 2024 by benzinga